March 17, 2021 Webinar
11:00 am – 12:00 pm EST
Register here.
In 2021, the COVID-19 pandemic continues to raise a number of issues specific to public companies that file reports with the US Securities and Exchange Commission.
During this webinar hosted by Intelligize, Laura Richman and Christina Thomas will address these issues, specifically
In this microtalk video, Jennifer Carlson provides a detailed overview of the US Securities and Exchange Commission’s adopted rule, Regulation Fair Disclosure (“Reg FD”), while also addressing consequences of public companies’ non-compliance.
Visit our MB Microtalk page for more topics and talks.
On February 24, 2021, Acting Chair of the US Securities and Exchange Commission (“SEC”), Allison Herren Lee, announced that the agency will be focusing on public companies’ climate change disclosures as part of an effort to both assess current compliance with federal securities laws and develop new disclosure requirements for climate change. Specifically, she stated
The Public Company Accounting Oversight Board (PCAOB) recently released an interim analysis report on the initial impact of critical audit matter (CAM) requirements (Auditing Standard No. 3101). Generally, CAM requirements are meant to identify audit matters that required especially challenging, subjective, or complex auditor judgment and to describe how the auditor responded to
In the International Financial Law Review’s latest publication, A Deep Dive Into Capital Raising Alternatives, Mayer Brown provides context on the changes in market structure and market dynamics that led to the enactment of the JOBS Act. Specifically, the trend for many private companies to remain private longer, defer or dispense with traditional
November 2, 2020 Webinar
9:00 a.m. to 10:00 a.m. EDT
Register here
SPACs continue to grow in popularity and significance in the US. Despite COVID-19, US capital markets remain active for SPAC IPOs. Many emerging companies are receiving indications of interest from SPACs seeking acquisition candidates. Our session focuses on helping management teams and boards
Thursday, October 22, 2020
1:00pm – 2:00pm EDT
Register here.
Many companies are seeking alternatives to the traditional IPO, and considering merging into a SPAC, or a reverse merger. For life sciences companies, reverse merger transactions have become a popular alternative approach to going public. Merging into a public life sciences company that has
Webinar Event
October 13, 2020, 4:30pm EDT
Register here.
This year’s US ECM Roundtable will be held as a virtual two-part series, which will bring together senior market professionals to assess current themes in the industry and provide an outlook for the future.
The second session, SPACs Boom onto the Market in 2020 as
On September 11, 2020, the U.S. SEC adopted amendments to the requirements for statistical disclosures that bank and savings and loan registrants provide to investors. The rules rescind Industry Guide 3, Statistical Disclosure by Bank Holding Companies (Guide 3); codify certain Guide 3 disclosures into a new Subpart 1400 of Regulation S-K; eliminate other Guide
On September 23, 2020, the US Securities and Exchange Commission adopted amendments to Rule 14a-8 promulgated under the Securities Exchange Act of 1934. The amendments will generally be effective for shareholders’ meetings to be held on or after January 1, 2022. This Legal Update provides background and details on the amendments and notes practical considerations